The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 55.00
Ask: 55.80
Change: -0.80 (-1.42%)
Spread: 0.80 (1.455%)
Open: 56.60
High: 56.60
Low: 56.00
Prev. Close: 56.20
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Employee Benefit Trust and Directors' Interests

20 Jul 2016 16:37

RNS Number : 7852E
Accsys Technologies PLC
20 July 2016
 

 

 

AIM: AXS

Euronext Amsterdam: AXS

20 July 2016

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Employee Benefit Trust and Directors' Interests

 

Further to the Company's previous announcements, including on 30 June 2015, awards over 938,449 ordinary shares of €0.05 each in the Company ("Shares") held by the Accsys Employee Benefit Trust ('EBT') vested on 15 July 2016. These awards were granted in line with the Company's employee remuneration and incentivisation arrangements and related to the year ended 31 March 2015.

 

Certain beneficiaries elected to sell a total of 498,318 Shares on the open market to fund the resulting personal tax liabilities (amongst other reasons), including the executive directors whose names are set out below. 266,000 shares were sold at £0.651353 per Share on 15 July 2016 and 232,318 were sold on 19 July 2016 at £0.614079 per Share. The Venue of Execution was The London Stock Exchange (XLON).

 

Details concerning Directors' Share sales from the EBT are set out below;

 

Name

Number of €0.05 Shares vested

Number of €0.05 Shares subsequently sold

Number of €0.05 of Shares subsequently sold on 15 July 2016

Number of €0.05 of Shares subsequently sold on 19 July 2016

Paul Clegg

266,549

166,549

83,274

83,275

Hans Pauli

106,942

56,942

28,471

28,471

William Rudge

81,547

40,773

20,386

20,387

 

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, Executive Director, Corporate Development

Will Rudge, FD

 

 via MHP Communications

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

James White

Tess Harris

 

+44 (0) 20 3128 8100

 

Off the Grid (The Netherlands)

 

Frank Neervoort

Giedo Van Der Zwan

 

+31 681 734 236

+31 624 212 238

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc) and technology licencing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips, and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a wholly owned subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDRXXDBGLG
Date   Source Headline
21st Jul 20207:00 amRNSBoard Appointment of Alexander Wessels
15th Jul 20205:59 pmRNSDirector Interests and LTIP Awards
30th Jun 20209:16 amRNSTotal Voting Rights
23rd Jun 20203:58 pmRNSIssue of Shares and Directors' Interests
23rd Jun 20207:14 amRNSPreliminary Results for the year ended 31 March 20
15th Jun 20205:37 pmRNSNotifiable Interest – Teslin
29th May 20205:37 pmRNSTotal Voting Rights
19th May 20207:00 amRNSAppointment of Chairman Designate
12th May 20204:03 pmRNSNotifiable Interest - BGF
7th May 202011:08 amRNSIssuance of Shares
27th Mar 202012:03 pmRNSCOVID-19 Update
4th Mar 20209:36 amRNSNotifiable Interest - De Engh B.V.
28th Feb 202010:26 amRNSTotal Voting Rights
24th Feb 20207:00 amRNSCommercial Agreements with Cerdia Produktions GmbH
17th Feb 20202:18 pmRNSNotifiable Interest - De Engh B.V.
4th Feb 20203:46 pmRNSEmployee Share Participation Plan
27th Dec 20197:00 amRNSNotifiable Interest - Janus Henderson Group
27th Dec 20197:00 amRNSNotifiable Interest - De Engh B.V.
24th Dec 201910:11 amRNSNotifiable Interest - Pershing Securities Limited
23rd Dec 20192:00 pmRNSDirector Dealings
23rd Dec 20197:00 amRNSAdmission and Total Voting Rights
20th Dec 201910:07 amRNSSuccessful Results of General Meeting
20th Dec 20197:00 amRNSResults of Firm Placing and Placing and Open Offer
2nd Dec 201911:14 amRNSDirector Interests and LTIP Awards
28th Nov 20192:16 pmRNSPublication of a Prospectus
28th Nov 20197:01 amRNSInterim Results for six months ending 30 Sept 2019
28th Nov 20197:00 amRNSEquity Raise
18th Oct 20197:00 amRNSAppointment of Chief Executive Officer
30th Sep 20195:17 pmRNSAGM Results
30th Sep 20197:00 amRNSAGM Statement
17th Sep 20196:03 pmRNSNotifiable Interest - Majedie Asset Management
12th Aug 20193:13 pmRNSAGM Notification
2nd Aug 20197:00 amRNSNotifiable Interest - Teslin Participaties
17th Jul 201911:27 amRNSShare purchase by a PDMR
28th Jun 201912:04 pmRNSShare Purchase by PCA
25th Jun 20195:58 pmRNS20190625 - AXS - Directors Interest LTIP
25th Jun 20197:00 amRNSDirectorate Change
25th Jun 20197:00 amRNSPreliminary results for year ended 31 March 2019
30th Apr 20197:00 amRNSAppointment of joint broker
29th Mar 20199:01 amRNSTotal Voting Rights
25th Mar 20197:00 amRNSTrading Update Year Ending March 2019
4th Mar 20195:31 pmRNSShare purchase by a PCA
15th Feb 20197:00 amRNSIssuance of Shares
9th Jan 20197:00 amRNSAgreement with PCG to evaluate Tricoya® plant
21st Dec 20187:03 amRNSResignation of Director
20th Nov 20187:00 amRNSInterim Results for six months ending 30 Sept 2018
24th Sep 20187:00 amRNSAGM Correction Statement
18th Sep 20184:00 pmRNSAGM - Proxy Results
18th Sep 20187:00 amRNSAGM Statement
14th Aug 20187:00 amRNSNotifiable Interest - BGF

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.